0001093557-17-000080.txt : 20170315
0001093557-17-000080.hdr.sgml : 20170315
20170315203953
ACCESSION NUMBER: 0001093557-17-000080
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170309
FILED AS OF DATE: 20170315
DATE AS OF CHANGE: 20170315
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leach Jacob Steven
CENTRAL INDEX KEY: 0001700255
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 17692704
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
edgardoc.xml
PRIMARY DOCUMENT
X0206
3
2017-03-09
0
0001093557
DEXCOM INC
DXCM
0001700255
Leach Jacob Steven
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
SVP, Research & Development
Common Stock
105933
D
Common Stock
12000
I
Family Holdings
Common Stock
50100
I
by Spouse
Incentive Stock Option (right to buy)
3.19
2018-12-11
Common Stock
10577
D
Incentive Stock Option (right to buy)
5.92
2018-10-02
Common Stock
25000
D
Incentive Stock Option (right to buy)
7.27
2019-11-20
Common Stock
4797
D
Incentive Stock Option (right to buy)
7.63
2018-05-19
Common Stock
7500
D
Incentive Stock Option (right to buy)
9.78
2020-02-18
Common Stock
11458
D
Non-Qualified Stock Option (right to buy)
3.19
2018-12-11
Common Stock
1923
D
Non-Qualified Stock Option (right to buy)
7.27
2019-11-20
Common Stock
203
D
Non-Qualified Stock Option (right to buy)
9.78
2020-02-18
Common Stock
8542
D
Included in this number are 57,800 unvested restricted stock units, 23,134 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 21,333 of which were granted on March 8, 2016 shall vest through March 8, 2019 and 13,333 of which were granted on March 8, 2015 and shall vest through March 8, 2018.
Shares are held by the Gregg Family Grandchildren's Trust UAD 12/30/2010, with respect to which the reporting person's spouse is a trustee.
Shares are held by the Kyndra S. Leach Trust UAD 12/12/2012, with respect to which the reporting person's spouse is a trustee.
Shares subject to the option are fully vested and immediately exercisable.
CONFIRMING STATEMENT: This Statement confirms that the undersigned Jacob Leach, has authorized and designated Steve Pacelli, Kevin Sun, Patrick Murphy and Timothy O'Brien to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of DexCom, Inc. The authority of Steve Pacelli, Kevin Sun, Patrick Murphy and Timothy O'Brien under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of DexCom, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steve Pacelli, Kevin Sun, Patrick Murphy and Timothy O'Brien are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. Date: March 14, 2017 /s/ JACOB LEACH Jacob Leach
By: Timothy O'Brien For: Jacob Leach
2017-03-15